NeoGenomics, Inc. (NEO)
18.05
-0.59
(-3.17%)
USD |
NASDAQ |
Aug 28, 16:00
18.04
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Free Cash Flow : -7.355M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.355M |
| March 31, 2026 | -5.088M |
| December 31, 2025 | -21.78M |
| September 30, 2025 | -17.05M |
| June 30, 2025 | -19.17M |
| March 31, 2025 | -32.36M |
| December 31, 2024 | -34.04M |
| September 30, 2024 | -21.51M |
| June 30, 2024 | -29.73M |
| March 31, 2024 | -39.59M |
| December 31, 2023 | -30.70M |
| September 30, 2023 | -49.65M |
| June 30, 2023 | -64.00M |
| March 31, 2023 | -82.24M |
| December 31, 2022 | -96.88M |
| September 30, 2022 | -120.43M |
| June 30, 2022 | -119.06M |
| March 31, 2022 | -114.50M |
| December 31, 2021 | -90.86M |
| September 30, 2021 | -64.62M |
| June 30, 2021 | -49.21M |
| March 31, 2021 | -29.62M |
| December 31, 2020 | -27.64M |
| September 30, 2020 | -24.83M |
| June 30, 2020 | -6.184M |
| Date | Value |
|---|---|
| March 31, 2020 | -11.20M |
| December 31, 2019 | 3.34M |
| September 30, 2019 | 18.29M |
| June 30, 2019 | 13.21M |
| March 31, 2019 | 23.73M |
| December 31, 2018 | 30.48M |
| September 30, 2018 | 20.48M |
| June 30, 2018 | 19.38M |
| March 31, 2018 | 18.69M |
| December 31, 2017 | 4.347M |
| September 30, 2017 | -0.338M |
| June 30, 2017 | 2.249M |
| March 31, 2017 | 3.19M |
| December 31, 2016 | 13.94M |
| September 30, 2016 | 17.98M |
| June 30, 2016 | 12.13M |
| March 31, 2016 | 11.86M |
| December 31, 2015 | 4.178M |
| September 30, 2015 | 2.523M |
| June 30, 2015 | 3.064M |
| March 31, 2015 | 3.907M |
| December 31, 2014 | 5.678M |
| September 30, 2014 | 4.715M |
| June 30, 2014 | 3.623M |
| March 31, 2014 | 1.927M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Precipio, Inc. | 0.789M |
| Guardant Health, Inc. | -228.54M |
| Quest Diagnostics, Inc. | 1.349B |
| Labcorp Holdings, Inc. | 1.155B |
| OPKO Health, Inc. | -134.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 19.96M |
| Cash from Investing (Quarterly) | -8.319M |
| Cash from Financing (Quarterly) | -12.24M |
| Free Cash Flow Per Share (Quarterly) | 0.0897 |
| Free Cash Flow to Equity (Quarterly) | -28.10M |
| Free Cash Flow to Firm (Quarterly) | 12.70M |
| Free Cash Flow Yield | -0.32% |